Miia Kivipelto, MD, PhD is Professor in Clinical Geriatric Epidemiology at Karolinska Institutet, Center for Alzheimer Research, senior geriatrician and Head of the Clinical Trials Unit at the Memory Clinic, Karolinska University Hospital, where she is also Director of Research, Development and Education. She became recently the change leader of the new theme area ‘Aging’ at New Karolinska Hospital. Dr Kivipelto is also Research Director of Neuroepidemiology at the University of Eastern Finland and senior researcher at the National Institute of Health and Welfare, Helsinki, Finland.
Dr. Kivipelto’s research focuses on the prevention, early diagnosis and treatment of cognitive impairment, dementia and Alzheimer’s disease. Through epidemiological studies she has identified various lifestyle risk factors for dementia. Based on these observations, she launched the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), which is the first large long-term randomized controlled trial indicating that multidomain intervention could improve or maintain cognitive functioning in at-risk elderly people from the general population. She is also principal investigator of the Multimodal Preventive Trials for Alzheimer’s Disease: Towards Multinational Strategies (MIND-AD) project and lead for the Nordic countries for the European Prevention of Alzheimer Dementia (EPAD) consortium.
Furthermore, Dr Kivipelto initiated the Nordic Brain Network, and co-founded the European Dementia Prevention Initiative. She received numerous prestigious awards, including the Waijlit and Eric Forsgren’s award for outstanding dementia research (2015), Best PI at KI award (2014), AXA Research Award (2014), Karolinska Institutet Skandia’s Lennart Levi prize (2013), Junior Chamber International Award for Ten Outstanding Young Persons of the World (2011), and Academy of Finland Award for Social Impact (2009).
Due to her expertise, Professor Kivipelto is often invited to leading conferences and international steering committees, including the G8 Dementia Summit, OECD data mapping for Alzheimer research, and WHO Ministerial meeting on Global actions against dementia.